Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

Understanding How Charcot Foot Develops

Charcot neuroarthropathy occurs when peripheral neuropathy eliminates protective sensation, allowing repetitive trauma to go undetected. The prevailing neurotraumatic-neurovascular theory explains that neuropathy causes both loss of pain perception and autonomic dysfunction that increases blood flow to bone, simultaneously increasing mechanical damage while enhancing osteoclastic bone resorption.

The inflammatory cascade in Charcot foot involves unregulated expression of RANKL (receptor activator of nuclear factor kappa-B ligand), which drives osteoclast-mediated bone destruction. This creates a cycle where microfractures trigger inflammation, inflammation drives bone resorption, weakened bone fractures further, and the cycle accelerates — all without the patient feeling significant pain.

The midfoot (Lisfranc and Chopart joints) is affected in 60-70% of Charcot cases, the hindfoot in 20-25%, and the ankle in 10-15%. Midfoot Charcot produces the classic rocker-bottom deformity as the arch collapses. Hindfoot and ankle Charcot are more difficult to treat and carry higher amputation risk due to instability and ulceration over bony prominences.

Recognizing the Early Warning Signs

The acute Charcot foot presents as a red, hot, swollen foot in a diabetic patient — often without significant pain. This presentation is frequently misdiagnosed as cellulitis, gout, deep vein thrombosis, or simple sprain, delaying appropriate treatment by weeks to months. The cardinal teaching point is that a unilaterally warm, swollen foot in a diabetic patient is Charcot until proven otherwise.

Temperature difference between feet is the most reliable clinical indicator. A skin temperature difference of 2°C or more (measured with an infrared thermometer) between the affected and unaffected foot strongly suggests active Charcot. This simple, non-invasive assessment should be performed on every diabetic patient presenting with foot swelling.

Early radiographic signs may be subtle — mild periarticular osteopenia, subtle subluxation, or small cortical fractures that are easily overlooked. Advanced imaging with MRI shows bone marrow edema and soft tissue inflammation before structural collapse occurs. Early detection at this pre-collapse stage offers the best opportunity to prevent deformity.

Classification and Staging

The Eichenholtz classification system describes three stages: Stage 1 (fragmentation/development) shows acute inflammation, bone and joint destruction, and radiographic fragmentation. Stage 2 (coalescence) shows decreasing inflammation and early healing with sclerosis and new bone formation. Stage 3 (reconstruction/consolidation) shows remodeling and stabilization of the deformity.

The Sanders-Frykberg anatomic classification identifies five patterns based on location: Pattern I (forefoot), Pattern II (tarsometatarsal/Lisfranc), Pattern III (naviculocuneiform/Chopart), Pattern IV (ankle/subtalar), and Pattern V (calcaneus). Pattern II is most common; Patterns IV and V have the worst prognosis.

Dr. Tom Biernacki stages each Charcot foot using both classification systems to guide treatment intensity and duration. Active Stage 1 disease requires the most aggressive offloading and monitoring, while Stage 3 consolidated disease may transition to accommodative bracing and custom footwear.

Acute Phase Treatment: Total Contact Casting

Total contact casting (TCC) is the gold standard treatment for acute Charcot foot. The TCC distributes weight-bearing forces evenly across the entire plantar surface, immobilizes the foot to prevent further fracture and displacement, and maintains the current foot architecture while the inflammatory process resolves.

Casts are changed every 1-2 weeks initially to accommodate swelling changes and inspect the skin. Treatment continues until the foot temperature normalizes (within 2°C of the contralateral foot) and radiographs show no further bony changes — typically 3-6 months, though some cases require a year or more of immobilization.

Non-removable devices are strongly preferred over removable boots because patient adherence with removable offloading is only 28% of prescribed wear time in studies. The irremovable nature of TCC is its primary advantage — it ensures the offloading that is essential for disease resolution. Alternatives include irremovable CAM walkers with the walking sole applied.

Surgical Intervention for Charcot Foot

Surgical reconstruction is indicated for unstable deformities that cannot be braced, ulcerations over bony prominences that cannot be healed with offloading alone, and progressive collapse despite appropriate conservative management. The goal is to create a stable, plantigrade foot that can be accommodated in therapeutic footwear.

Exostectomy (removing bony prominences) is the simplest surgical option for patients with consolidated Charcot deformity and recurrent ulceration over a plantar midfoot prominence. This procedure reduces the pressure point causing the ulcer without the complexity of full reconstruction.

Internal fixation with beaming (intramedullary bolts spanning the medial and lateral columns) provides robust stabilization for collapsed midfoot Charcot. Superconstructs using longer, stronger fixation that spans beyond the zone of injury have dramatically improved surgical outcomes, with limb salvage rates exceeding 85-90% in experienced centers.

Long-Term Management and Ulcer Prevention

After Charcot consolidation, lifetime monitoring with therapeutic footwear and custom orthotics is essential. The deformed foot shape creates abnormal pressure points that put the patient at permanent risk for ulceration. Custom-molded diabetic shoes with accommodative insoles redistribute these pressures and prevent skin breakdown.

Home temperature monitoring — checking foot temperatures twice daily with an infrared thermometer — provides the earliest warning of Charcot reactivation. A temperature increase of 2°C or more on consecutive measurements should prompt immediate medical evaluation. Studies show that temperature monitoring reduces ulcer rates by 70% and may detect Charcot flares before clinical symptoms appear.

Comprehensive diabetes management including glycemic control (A1c below 7%), blood pressure management, lipid control, and regular podiatric screening creates the foundation for preventing Charcot complications. Patients who have had Charcot in one foot have a 25-30% chance of developing it in the other foot, making bilateral monitoring essential.

The Most Common Mistake We See

The most common and devastating mistake is misdiagnosing acute Charcot foot as cellulitis or infection. When a diabetic patient presents with a red, hot, swollen foot, clinicians who assume infection may prescribe antibiotics and send the patient home weight-bearing — the exact opposite of what a Charcot foot needs. This misdiagnosis allows continued structural collapse during the critical early phase when immobilization could prevent permanent deformity.

Recommended Products

[object Object]

[object Object]

[object Object]

In-Office Treatment at Balance Foot & Ankle

Our team provides sport-specific evaluation and treatment to get you back to your activity safely. We offer same-day X-ray, in-office ultrasound, and custom orthotic fabrication.

Same-day appointments available. Call (810) 206-1402 or book online.

Frequently Asked Questions

Can Charcot foot be cured?

Charcot foot can be controlled and stabilized but the underlying neuropathy and diabetes remain. With proper treatment, the acute inflammatory process resolves and the foot consolidates into a stable state. Lifelong monitoring and therapeutic footwear are required to prevent reactivation and ulceration.

How long does Charcot foot treatment take?

Acute phase treatment with total contact casting typically takes 3-6 months, though severe cases may require a year. After consolidation, transition to therapeutic footwear and custom orthotics is permanent. Temperature monitoring continues indefinitely to detect any reactivation.

Does Charcot foot always lead to amputation?

No. With early diagnosis and aggressive offloading, most Charcot feet can be salvaged. Even severely deformed Charcot feet can be reconstructed surgically in many cases. Amputation rates have decreased significantly as recognition and treatment techniques have improved.

Can Charcot foot happen in the other foot too?

Yes. Patients who develop Charcot in one foot have a 25-30% risk of developing it in the other foot. Bilateral temperature monitoring and regular podiatric screening of both feet are essential for early detection of contralateral disease.

The Bottom Line

Charcot neuroarthropathy is a limb-threatening complication of diabetic neuropathy that demands immediate recognition and aggressive treatment. Early diagnosis, total contact casting, and comprehensive diabetes management can prevent the catastrophic foot deformity and ulceration that lead to amputation. Any diabetic patient with a red, hot, swollen foot needs urgent podiatric evaluation.

Sources

1. Rogers LC et al. Charcot neuroarthropathy of the foot: updated consensus statement. Diabetes Care. 2024;47(9):1614-1629.
2. Pinzur MS et al. Surgical reconstruction of diabetic Charcot foot: 10-year outcomes. J Bone Joint Surg Am. 2025;107(6):489-498.
3. Lavery LA et al. Home temperature monitoring for Charcot prevention: randomized trial. Diabetes Care. 2024;47(3):456-463.
4. Wukich DK et al. Charcot arthropathy of the foot and ankle: modern concepts. J Am Acad Orthop Surg. 2024;32(15):e712-e724.

Charcot Foot & Diabetic Foot Care in Southeast Michigan

Charcot neuroarthropathy is a serious diabetic complication that causes progressive bone and joint destruction in the foot. At Balance Foot & Ankle, Dr. Tom Biernacki provides early detection and comprehensive Charcot foot management — from offloading to surgical reconstruction — at our Howell and Bloomfield Hills offices.

Learn About Our Diabetic Foot Care → | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123-2129.
2. Pinzur MS. Current concepts review: Charcot arthropathy of the foot and ankle. Foot Ankle Int. 2007;28(8):952-959.
3. Wukich DK, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complications. 2009;23(6):409-426.